Better living through peptide-conjugated chemistry: next-generation antisense oligonucleotides. (2019)

First Author: McNally EM
Attributed to:  Advanced peptide-oligonucleotide therapy for Myotonic Dystrophy Type 1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci131933

PubMed Identifier: 31566581

Publication URI: http://europepmc.org/abstract/MED/31566581

Type: Journal Article/Review

Volume: 129

Parent Publication: The Journal of clinical investigation

Issue: 11

ISSN: 0021-9738